Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real-World Evidence.
Saved in:
| Title: | Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real-World Evidence. |
|---|---|
| Authors: | Cerono G; Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA., Cree BAC; Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA., Hauser SL; Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA., Baranzini SE; Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA. |
| Source: | Annals of neurology [Ann Neurol] 2026 Jan; Vol. 99 (1), pp. 248-260. Date of Electronic Publication: 2025 Sep 08. |
| Publication Type: | Journal Article; Comparative Study |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7707449 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-8249 (Electronic) Linking ISSN: 03645134 NLM ISO Abbreviation: Ann Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1531-8249 |
|---|---|
| DOI: | 10.1002/ana.78033 |
